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Alopecia areata is an autoimmune disease that targets
actively growing (anagen) hair follicles in humans,
mice, rats, dogs, horses, and cattle. C3H/HeJ mice spon-
taneously develop alopecia areata from 5 mo of age and
older in females and later in males. Frequency of disease
approached 20% in a colony by 18 mo of age. C57BL/6J
mice do not develop alopecia areata. A segregating F2
population of female mice (n¼1096) was generated
from crossing these two strains. Alopecia areata
(n¼138) and clinically normal (n¼ 214) mice were gen-
otyped at 12 mo of age using 211 microsatellite probes.
The peak logarithm of odds ratio score on mouse chro-
mosome 17 (10.9) was around marker D17Mit134 at 16.9
cM from the centromere.The mouse histocompatibility
locus, H2, the mouse equivalent of human leukocyte
antigen in humans, was a likely candidate. Twelve-
month-old C3H.SW-H2b/SnJ mice (C3H/HeJ congenic
mice in which the H2k purported susceptibility locus
was replaced with the H2b purported resistance locus)
did not develop alopecia areata, supporting this locus
as being important in alopecia areata. A suggestive
linkage was also found on mouse Chromosome 9 (loga-
rithm of odds ratio score 2.0) around D9Mit206, 20 cM
from the centromere. The interval on mouse Chromo-
some 17 contains several orthologous genes potentially
associated with human alopecia areata. Key words: auto-
immune disease/H2/HLA/mouse models. J Invest Dermatol
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A
lopecia areata (AA) in humans is a suspected auto-
immune disease that targets hair follicles in the ac-
tively growing anagen stage. AA is associated with a
heterogeneous phenotype. Patients with AA often
develop alopecic lesions of various sizes on any site
of haired skin on the body. These foci of alopecia wax and wane
either resolving completely or extending to involve the entire
scalp (alopecia totalis) or the entire body (alopecia universalis).
Nearly 2% of the general population will develop some form of
AA during their lives (Safavi et al, 1995). The pathogenesis of AA
involves activation of the cell-mediated immune system by unde-
¢ned antigen(s) through the lymphocyte costimulatory cascade
with activated CD4þ and CD8þ T cells targeting anagen stage
hair follicles (Carroll et al, 2002). AA is most likely a disorder of
multifactorial etiologies comprising immunologic, environmen-
tal, and genetic components. A strong genetic in£uence is sup-
ported by increased concordance in identical twins (Hendren,
1949; Weidman et al, 1956; Barsky and Gigli, 1961; Bonjean et al,
1968; Cole and Herzlinger, 1984;Werth et al, 1992) or siblings (Ins-
ler and Helm, 1989) as well as identi¢cation of families with sev-
eral generations of members with AA (Hordinsky et al, 1984; Van
der Steen et al, 1992; Dawn and Kumar, 1996). Human AA gene
association studies focus on the major histocompatibility locus,
HLA, as the most likely region for genes that regulate susceptibil-
ity or resistance to AA, as AA is considered to be an autoimmune
disease (Duvic et al, 1991; Morling et al, 1991; Welsh et al, 1994;
Colombe et al, 1999; deAndrade et al, 1999; Kavak et al, 2000).
Increased association of human AA with other autoimmune
diseases in the same individual and/or in blood relatives of af-
fected people also suggests that AA patients have an inherited sus-
ceptibility to autoimmune diseases (Muller and Winkelmann,
1963; Gollinck and Orfanos, 1990; Shellow et al, 1992). AA is not
a disease unique to humans. Mice, rats, dogs, horses, cattle, and
possibly other species develop various forms of AA (Sundberg
et al, 1995; in press; McElwee et al, 1998b). At least eight inbred
and one congenic strains of mice develop AA-like diseases, one
of which consistently develops abnormalities of nails as well as
alopecia, similar to a subpopulation of human patients with AA
(McElwee et al, 1999).Within inbred strains of mice spontaneous
AA can approach a frequency of 20% (Sundberg et al, 1994). The
best characterized and most studied of these mouse strains with
AA is the C3H/HeJ inbred strain (Sundberg et al, in press). In this
study, genome-wide screens were done, using mapping methods
for single and multiple loci, in a segregating F2 population from
C3H/HeJ female mice with AA that were crossed with normal
C57BL/6J mice. Their progeny were intercrossed to produce F2
o¡spring in order to identify loci responsible for susceptibility
to AA. Two genetic intervals were identi¢ed. One interval on
mouse chromosome (m. Chr.) 17 includes the homologous HLA
interval associated with human AA. Twelve-month-old congenic
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C3H mice that had this interval exchanged with a resistant inter-
val did not develop AA, providing support for the mapping re-
sults. A candidate interval on m. Chr. 9 was also identi¢ed.
MATERIALS AND METHODS
Mice Female C3H/HeJ mice that spontaneously developed AA and
clinically normal C57BL/6J males that never develop AA were obtained
from The Jackson Laboratory (Bar Harbor, ME). These mice were
intercrossed to generate F2 mice that were subsequently followed until 1 y
of age. Initial evaluation of the ¢rst 462 F2 mice revealed that 10% of
females and 2% of males developed AA. Because of the late onset of AA
in male mice (12^15 mo of age for males compared to 6^8 mo for females)
and a lower prevalence in males, only females were aged in subsequent F2
populations. A total of 1096 F2 female mice were observed for 12 mo to
determine which developed clinical and histologic evidence of AA. Of
these 138 developed disease. These 138 mice with AA, along with 214
clinically normal littermates, were subjected to genome-wide screens. All
work was performed with approval of The Jackson Laboratory IACUC.
Congenic C3H.SW-H2b/SnJ mice, in which the C3H/HeJ-H2k locus was
replaced with H2b, were also obtained fromThe Jackson Laboratory. A total
of 85 retired female mice were aged to 12 mo or older and observed weekly
for any evidence of alopecia.
Mice were maintained in a humidity-, temperature-, and light cycle
(12:12) controlled vivarium under speci¢c pathogen-free conditions
(Sundberg et al, 1994; McElwee et al, 1998a). Mice were caged in double-
pen polycarbonate cages (330 cm2 £oor area) at a maximum capacity of
four mice per pen. Mice were allowed free access to autoclaved food
(NIH diet 31, 6% fat) and acidi¢ed water (pH 2.8^3.2). Only female F2
were maintained, evaluated weekly, and necropsied at 12 mo of age.
Phenotyping mice All mice were examined for evidence of AA by
trained personnel on a weekly basis. A¡ected mice initially developed
focal alopecia on their ventral abdomen near the rear legs that spread with
approximately lateral symmetry to involve the entire ventral skin.
Concurrently, focal areas of alopecia developed randomly on the dorsal
skin. These waxed and waned. Over periods of months, the majority of
a¡ected female mice developed generalized alopecia similar to alopecia
universalis in humans. Mice were euthanized by CO2 asphyxiation and
necropsies were performed. Representative skin was collected from dorsal
and ventral trunk, placed on aluminum foil to lay the tissue £at and orient
it in a cranial to caudal manner, then ¢xed by immersion in Fekete’s acid^
alcohol^formalin, transferred after overnight ¢xation into 70% ethanol,
trimmed, embedded in para⁄n, sectioned at 6 mm, stained with
hematoxylin and eosin, and examined by an experienced pathologist
(JPS). A minimum of three strips of skin from both the dorsal and ventral
thoracic regions (six minimum) 41.0 cm in length were examined
histologically. In mice with AA, anagen stage truncal hair follicles were
in¢ltrated or surrounded to various degrees by in£ammatory cells that
were predominantly lymphocytes (Sundberg et al, 1994). Mice were scored
using both gross and/or histologic criteria as having AA or being clinically
normal. Peripheral blood £uorescence-activated cell sorter analyses or other
hormonal and biochemical assays had not identi¢ed a scoreable dichotomy
to permit quantitative trait analyses (Sundberg et al, 1994).
Genotyping DNAwas isolated from tail tips amputated at the time of
necropsy. DNAwas extracted using a DNeasy kit (Qiagen,Velencia, CA).
DNAs from all F2 segregants were genotyped by polymerase chain
reaction using microsatellite markers purchased from Research Genetics
(Huntsville, AL). Thermal cyclers (MJ Research, Cambridge, MA) were
used, and products were separated on 4% Metaphor/LE (3:1) agarose gels
(BMA Biomedicals). The Jackson Laboratory’s allele typing service also
provided multiplex genotyping data by using ABI 370 instrumentation
(http://jaxmice.jax.org). To distinguish between C3H and B6, 211
informative microsatellite markers were used, initially providing coverage
of at least every 20 cM on each autosome and m. Chr. X (Mahler et al, 1999;
Farmer et al, 2001).The list of markers is available on request. Linkage maps
and marker positions reported are based onThe Jackson Laboratory’s online
Mouse Genome Informatics resource (www.informatics.jax.org).
Statistical analysis Genome scans were carried out by using both
marker regression and interval mapping analysis. Because similar results
were obtained by using both methods, only the results of interval
mapping are presented. Logarithm of odds ratio (LOD) scores for main
e¡ects were computed at 2 cM intervals across the autosomal genome,
and LOD scores for pairwise scans were done at 5 cM resolution.
Interpretation of results was simpli¢ed by focusing on the individual trait
of AA versus clinical normality. Pairwise interactions among loci were
assessed by using genome-wide scans (Sen and Churchill, 2001; Sugiyama
et al, 2001). Brie£y, the signi¢cance of a pair of loci was assessed ¢rst by
using an overall F test (with 8 and 399 degrees of freedom) for a two-way
ANOVA model of genotypic e¡ects.When this test exceeded the genome-
wide threshold as established by permutation analysis, secondary tests were
carried out to test for an interaction e¡ect. If an interaction was indicated,
testing was stopped and an interacting pair was declared. If no signi¢cant
evidence for interaction was uncovered, each of the single models was
compared with the two quantitative trait locus (QTL) additive model.
Both tests must be signi¢cant to indicate an additive pair. These
secondary tests were carried out at a nominal 0.005 level to account for
testing of more than one but fewer than 10 potential pairs. All software
used in this analysis are available at www.jax.org/research/churchill or by
request (GAC).
RESULTS
Frequency of AA Initially we used an intercross between
C3H/HeJ females with AA and CAST/EiJ. This strategy would
have yielded numerous polymorphisms in regions of potential
interest. None of the 295 F2 mice from this cross developed AA,
however. These studies were terminated and we reverted to an
intercross strategy between a¡ected C3H/HeJ females and
C57BL/6J males, a strain that does not develop AA. The ¢rst
group of F2 mice generated 23 out of 229 (10%) females and
¢ve out of 233 (2%) males with AA (total 28 of 462, 6%).
Subsequently only F2 females were aged, yielding 138 mice
(12.6%) with AA from a total of 1096 mice. A genome-wide
screen used 211 microsatellite markers on 138 AA and 214
clinically normal mice. At the time of necropsy there
was concordance between clinically evident alopecia and
histologically con¢rmed AA.
Genetic linkage analysis Two intervals were identi¢ed that
were statistically sign¢cant or suggestive of linkage (Figs 1^3,
Table I). The m. Chr. 17 interval includes H2 (human HLA
ortholog, Fig 4), tumor necrosis factor a (Tnfa), lymphotoxin a
Figure 2. Fine mapping, at 2 cM intervals, of m. Chr. 9 revealed
one, possibly two, suggestive intervals involved in mouse AA.
LOD score is the solid line and posterior probability density score is the
dotted line.
Figure1. A scan at 5 cM resolution revealed a signi¢cant interval on
m. Chr. 17 and a suggestive one on m. Chr. 9. Based on a permutation
test, LOD scores of 1.8 or 2.2 correspond to a p-value of 0.10 and 0.05,
respectively.
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and b (Lfta, Lftb), and many other genes of interest (http://
informatics.jax.org). This 12^20 cM interval is still too large to
consider candidate genes. The broad range of statistical
signi¢cance on m. Chr. 17 suggests that multiple genes may be
involved. On m. Chr. 9 there was an interval suggestive of
linkage (LOD score of 2.0). Genes within this interval code for
proteins involved with T cell function (CD3D, CD3G, CD3E,
THY1, and regulatory T cell molecule, CRTAM), cytokines that
regulate in£ammation (IL10RA), or neural cell adhesion
molecule (NCAM1). Markers for NCAM are commonly used
by some laboratories to study mouse hair cycles (Paus et al, 1999).
The human homolog is 11q22^q24 (Fig 5). Pairwise analyses
failed to identify epistatic interactions with other genes.
None of the C3H.SW-H2b congenic female mice aged and
observed weekly until they were over 12 mo of age developed
AA, in contrast to C3H/HeJ mice that are H2k that routinely
develop AA at rates of up to 20% in females. The congenic
interval encompasses the interval identi¢ed as signi¢cant on m.
Chr. 17.
DISCUSSION
In previous research using DNA derived from humans, associa-
tion studies were conducted to con¢rm or refute a hypothesis.
The studies focused on a speci¢c gene to examine allele fre-
quency as associated with AA phenotype expression. In this
mouse genetic study, no hypotheses as to genes or loci involved
in AAwere predetermined. The entire genome was scanned with
microsatellite markers at approximately 20 cM intervals and can-
didate loci were identi¢ed by statistical analysis. This avoids any
potential bias in results that may be introduced in gene associa-
tion studies through the preselection of genes and loci for exam-
ination.Two intervals were identi¢ed in this mouse model linked
to spontaneous AA, one of which is in the H2 region homolo-
gous to HLA in humans associated with AA, further validating
this mouse model. The maximum LOD score was calculated by
¢tting results into a one, two, or three QTL model for a binary
trait. If the di¡erence between LOD scores for these criteria is
41.6, then it is interpreted that two or more QTLs are located
in that interval. There was not statistical evidence, based on the
numbers of mice available for analysis, for multiple QTLs at the
intervals on either m. Chr. 9 or 17 in this study.
There was a clear bias in AA phenotype expression in females
in both the inbred C3H/HeJ and F2 hybrid mice compared to
males. Early analyses of small groups of F2 mice did identify
an interval on m. Chr. X around DXMit172 (48.7 cM), just
distal to the androgen receptor gene (Ar, 36.0 cM). Signi¢cance
disappeared when all mice in this study were analyzed. Similar
Figure 3. Fine mapping, at 2 cM intervals, of m. Chr. 17 revealed a
highly signi¢cant interval that encompasses the MHC 2 complex.
LOD score is the solid line and posterior probability density score is the
dotted line.
Figure 4. M. Chr. 9 map with location and symbols for homologous
human genes within the AA susceptibility interval.The marker with
the peak LOD score is in the gray box. Potential candidate genes are in bold
type. Map modi¢ed from http://www.informatics.jax.org.
Table I. Signi¢cant or suggestive intervals involved in mouse AA
Chr Max LOD
for one QTL
Max LOD
for two QTLs
Max LOD
for three QTLs
95%
CI (cM)
% Variance
explaineda
Peak marker Marker
location
17 10.9 11.5 12.4 12^20 13.5 D17Mit134 16.9 cM
9b 2 2.7 3.2 0^35 2.6 D9Mit206 20.0 cM
aThe phenotypic variance explained is based on a single QTL model.
bSuggestive QTL.
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results have been reported in the human AA gene association
studies when more patients were tested (Barahamani et al,
2002). The bias in disease expression is probably due to gonadal
hormones. A sex bias in the frequency and age of female mice
at AA onset has been stated in previous published studies
(Sundberg et al, 1994). A study involving estradiol or testosterone
supplementation indicated that testosterone exerts an inhibitory
e¡ect on the development of AA (McElwee et al, 2001). As
such, the low level of AA in male F2 mice is probably the
result of testosterone, possibly acting to depress immune system
activity.
In the intercross study, gene mapping initially identi¢ed two
intervals, one being very signi¢cant on m. Chr. 17 and a second
with suggestive levels of signi¢cance on m. Chr. 9. The interval
of highest signi¢cance on m. Chr. 17 corresponds directly to
those found in human AA gene association studies. Human AA
has been shown to be associated with several MHC class II alleles,
HLA-DQ3, DR4, and DR11. Alleles DQB1n03 and DRB1n04 are
signi¢cantly associated with all forms of AAwhereas DRB1n1104,
DRB10401, and DQB1n0301 are speci¢cally associated with long-
standing and/or extensive alopecia totalis and universalis (Co-
lombe et al, 1995a; 1995b; Duvic et al, 1995). The highest signi¢-
cance was identi¢ed for D17Mit134 at 16.9 cM, less than 2 cM
from the homologous mouse genes for HLADQ (H2-Ab1, 18.64
cM) and HLADR (H2-Eb2, 18.67 cM) (www.informatics.jax.org).
Many other human autoimmune diseases have been shown to be
associated with a particular MHC class II haplotype (Theo¢lo-
poulos, 1995). Certain haplotypes seem to be associated with pre-
disposal of the individual towards autoimmunity (Campbell
and Milner, 1993; Corzo et al, 1995; Tomlinson and Bodmer,
1995; Blum and Miller, 2000). AA may have MHC class restric-
tion (Kianto et al, 1977; Hacham-Zadeh et al, 1981; Averbakh
and Pospelo, 1986; Frentz et al, 1986; Orecchia et al, 1987; Duvic
et al, 1991; Kuntz et al, 1997). A variety of immunoregulatory
genes are also found within this genetic interval, which may
ultimately prove to be important in this and other autoimmune
diseases.
The second interval of suggestive signi¢cance on m. Chr. 9
does not correspond to any other genes or intervals that are sug-
gestive in human AA gene association studies such as IL1 (Cox
et al, 1998; Tazi-Ahnini et al, 2001), IL1rn (Tarlow et al, 1994;
Barahamani et al, 2002), IL1b (Galbraith et al, 1999; Tazi-Ahnini
et al, 2001), Km1 (Galbraith and Pandey, 1989; Dugoujon et al,
1992; Dugoujon and Cambon-Thomsen, 1995; Galbraith et al,
1999), or Mx1 (Tazi-Ahnini et al, 2000). The identi¢cation of a
mouse m. Chr. 9 interval for an AA susceptibility allele is poten-
tially an important discovery, although the low LOD score tem-
pers enthusiasm. The locus de¢ned in this genome-wide screen is
still quite large and potentially encompasses numerous candidate
genes. These results suggest that m. Chr. 9 is worthy of closer ex-
amination, however, especially with CRTAM, CD3D, CD3E,
CD3G, andTHY1, all genes associated withTcell function, being
located within this interval.
Preliminary analyses of our data suggested more intervals of
signi¢cance, up to four, with one potential epistatic pair. As with
some of the human AA association studies, however (Barahamani
et al, 2002), signi¢cance diminished or disappeared as larger
groups were analyzed.
The C3H/HeJ AA mouse model has signi¢cant linkage with
the genetic interval that encompasses the major histocompatibil-
ity loci, as also seen with human AA gene association studies,
thus providing additional support for the validity of this model.
C3H.SW-H2b/SnJ congenic mice have had the C3H/HeJ-H2k re-
placed by H2b (as found in resistant C57BL/6J mice). Normal
C3H/HeJ mice with H2k develop AA by 12 mo of age to various
degrees based on sex. None of these congenic mice developed
AA, supporting this interval as being important in AA. Crosses,
currently in progress, between C3H/HeJ mice with clinically evi-
dent AA and C3H.SW-H2b/SnJ congenic mice will help dissect
out the genes involved in this region, something that cannot be
easily done with human families.
Figure 5. M. Chr. 17 map with location and symbols for homolo-
gous human genes within the AA susceptibility interval.The marker
with the peak LOD score is in the gray box. Potential candidate genes are in
bold type. Bracketed interval on the left indicates the approximate mapped lim-
its for the C3H.SW-H2b/SnJ congenic interval. Map modi¢ed from http://
www.informatics.jax.org.
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